Will the pig solve the transplantation backlog?

被引:223
作者
Cooper, DKC [1 ]
Gollackner, B [1 ]
Sachs, DH [1 ]
机构
[1] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Transplantat Biol Res Ctr, Boston, MA 02129 USA
来源
ANNUAL REVIEW OF MEDICINE | 2002年 / 53卷
关键词
antibodies; complement; primate; rejection; xenotransplantation;
D O I
10.1146/annurev.med.53.082901.103900
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The increasing shortage of human cadaveric organs for purposes of transplantation has become the critical limiting factor in the number of transplants performed each year. Some of this deficit is being met by the use of organs or partial organs from living donors, but this source is insufficient. Xenotransplantation-the transplantation of organs between species, namely from the pig to human-could provide a solution if immunologic and other associated problems could be solved. When a pig organ is transplanted into a primate, hyperacute rejection, induced by anti-pig antibody and mediated by complement and the coagulation system, develops rapidly. This immediate problem can now be overcome, but the return or persistence of anti-pig antibody leads to a delayed form of humoral rejection, acute humoral xenograft rejection, which leads to destruction of the organ within days or weeks. We review the various approaches being investigated to overcome this barrier. Whether they will also prevent subsequent acute cellular rejection remains unknown. Brief mention is made of the potential physiologic incompatibilities between pig and human organs, as well as the microbiologic safety aspects of xenotransplantation. Finally, the question of patient and societal acceptance of xenotransplantation is discussed.
引用
收藏
页码:133 / 147
页数:15
相关论文
共 46 条
[1]   The problem of anti-pig antibodies in pig-to-primate xenografting: current and novel methods of depletion and/or suppression of production of anti-pig antibodies [J].
Alwayn, IPJ ;
Basker, M ;
Buhler, L ;
Cooper, DKC .
XENOTRANSPLANTATION, 1999, 6 (03) :157-168
[2]   Effects of specific anti-B and/or anti-plasma cell immunotherapy on antibody production in baboons:: depletion of CD20-and CD22-positive B cells does not result in significantly decreased production of anti-αGal antibody [J].
Alwayn, IPJ ;
Xu, YX ;
Basker, M ;
Wu, C ;
Buhler, L ;
Lambrigts, D ;
Treter, S ;
Harper, D ;
Kitamura, H ;
Vitetta, ES ;
Abraham, S ;
Awwad, M ;
White-Scharf, ME ;
Sachs, DH ;
Thall, A ;
Cooper, DKC .
XENOTRANSPLANTATION, 2001, 8 (03) :157-171
[3]   Inhibition of xenoreactive natural antibody production by retroviral gene therapy [J].
Bracy, JL ;
Sachs, DH ;
Iacomini, J .
SCIENCE, 1998, 281 (5384) :1845-1847
[4]  
Bühler L, 2000, TRANSPLANTATION, V70, P1323
[5]  
Bühler L, 2000, TRANSPLANTATION, V69, P2296
[6]   Legal implications of xenotransplantation [J].
Chae, SJ ;
Cooper, DKC .
XENOTRANSPLANTATION, 1997, 4 (03) :132-139
[7]  
Cooper D. K., 2000, XENO PROMISE TRANSPL
[8]  
Cooper D.K.C., 1991, XENOTRANSPLANTATION, P481
[9]  
COOPER DKC, 1988, J HEART TRANSPLANT, V7, P238
[10]   OLIGOSACCHARIDES AND DISCORDANT XENOTRANSPLANTATION [J].
COOPER, DKC ;
KOREN, E ;
ORIOL, R .
IMMUNOLOGICAL REVIEWS, 1994, 141 :31-58